FDA Inspection 1009867 — BioLife Plasma Services LP

BioLife Plasma Services LP — FEI 1978019

The FDA completed an inspection of BioLife Plasma Services LP on April 20, 2017 in Springfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 20, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, MO (United States)